Marios K. Georgakis

75 M. Asias Str
Athens, ESYE31 11745, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 168 publications

Genetically Predicted Levels of Lipoprotein(a) and Risk of Cerebrovascular Disease.

Genetically Predicted Levels of Lipoprotein(a) and Risk of Cerebrovascular Disease.

Journal: Journal of the American Heart Association

Published: January 29, 2026

Genetic Variation in the Chemokine Network and Atherosclerosis Risk.

Genetic Variation in the Chemokine Network and Atherosclerosis Risk.

Journal: Current atherosclerosis reports

Published: January 24, 2026

Genetically proxied IL-6 signaling inhibition, lipoprotein(a) levels, and atherosclerotic disease risk.

Genetically proxied IL-6 signaling inhibition, lipoprotein(a) levels, and atherosclerotic disease risk.

Journal: Atherosclerosis

Published: January 21, 2026

Lipoprotein(a)-associated proteomic signature predicts cardiovascular disease in young adults.

Lipoprotein(a)-associated proteomic signature predicts cardiovascular disease in young adults.

Journal: The Journal of clinical investigation

Published: January 05, 2026

Genetically Proxied Interleukin-6 Signaling Inhibition and Heart Failure Risk.

Genetically Proxied Interleukin-6 Signaling Inhibition and Heart Failure Risk.

Journal: JACC. Heart failure

Published: November 19, 2025

Genetic Downregulation of Interleukin-6 Signaling and Arteriolosclerotic Cerebral Small Vessel Disease: A Drug Target Mendelian Randomization Analysis.

Genetic Downregulation of Interleukin-6 Signaling and Arteriolosclerotic Cerebral Small Vessel Disease: A Drug Target Mendelian Randomization Analysis.

Journal: Journal of the American Heart Association

Published: November 03, 2025

Anti-Inflammatory Therapies for Atherosclerotic Stroke Prevention.

Anti-Inflammatory Therapies for Atherosclerotic Stroke Prevention.

Journal: Neurology

Published: October 03, 2025

Longitudinal Association of a Polygenic Risk Score for Plasma T-Tau With Incident Alzheimer Dementia and Mild Cognitive Impairment.

Longitudinal Association of a Polygenic Risk Score for Plasma T-Tau With Incident Alzheimer Dementia and Mild Cognitive Impairment.

Journal: Neurology

Published: October 03, 2025

Genetically Simulated GLP-1 Receptor Agonism and Cerebral Small Vessel Disease.

Genetically Simulated GLP-1 Receptor Agonism and Cerebral Small Vessel Disease.

Journal: Neurology. Genetics

Published: September 26, 2025

Proteomic signatures as biomarkers of atherosclerosis burden.

Proteomic signatures as biomarkers of atherosclerosis burden.

Journal: Cardiovascular research

Published: September 26, 2025

Data-Driven Discovery of Novel Biology: From Genetics and Omics to Therapeutic Targets for Vascular Disease.

Data-Driven Discovery of Novel Biology: From Genetics and Omics to Therapeutic Targets for Vascular Disease.

Journal: JACC. Basic to translational science

Published: September 02, 2025

Cross-tissue omics-guided drug repurposing triangulates novel targetable mechanisms for Alzheimer's disease and candidate genetic biomarkers for treatment stratification.

Cross-tissue omics-guided drug repurposing triangulates novel targetable mechanisms for Alzheimer's disease and candidate genetic biomarkers for treatment stratification.

Journal: Research square

Published: August 13, 2025

Showing 1-12 of 168

Last Updated: 09/26/2026